Amisulpride

Therapeutic indications

Amisulpride is indicated for:

Acute and chronic schizophrenic disorders

Population group: both men and women, only adults (18 - 65 years old)

Amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Treatment 1: Oral - 100-1200 mg per day

Contraindications

Amisulpride is contraindicated in the following cases:

Renal insufficiency

Renal failure

Pituitary gland prolactinomas

Prolactinoma

Breast cancer

Malignant neoplasm of breast

Phaeochromocytoma

Phaeochromocytoma

Levodopa

Levodopa

Dopamine agonists

at least one of
Amantadine

Apomorphine

Bromocriptine

Cabergoline

Entacapone

Lisuride

Pergolide

Piribedil

Quinagolide

Ropinirole

Medication Recommendation

Receive personalized medication regimen for every patient case

Ask the Reasoner

Related medicines